ITGA2 and breast carcinoma: Additionally, analysis of whole exome sequencing of tumor biopsies from the Metastatic Breast Cancer Project showed a decrease in copy number of ITGB1 and variable expression of ITGA2 between primary tumors, soft tissue metastases, and bone metastases (Figure 4E).